ACTA1 and neoplasm: Although the mechanisms underlying the downregulation of Meflin expression in CAFs remain unknown, our data suggest that the balance of Meflin-positive CAFs and αSMA-positive CAFs in the TME could affect tumour progression and differentiation (Miyai et al., 2020).